Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers
Wenqiang Song(Vanderbilt University), Dana M. Brantley‐Sieders(Susan G. Komen Breast Cancer Foundation)
Cited by 95
Related Papers
The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling
|Journal of Clinical Investigation|2008|276
mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis
|PLoS Genetics|2015|47
Host deficiency in ephrin-A1 inhibits breast cancer metastasis
|F1000Research|2020|16
Host deficiency in ephrin-A1 inhibits breast cancer metastasis
|F1000Research|2020|15